Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-01-10 @ 2:32 PM
Study NCT ID:
NCT03300505
Status:
TERMINATED
Last Update Posted:
2025-05-13
First Post:
2017-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-24
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-28
First Submit QC Date:
None
Study First Post Date:
2017-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-14
Results First Submit QC Date:
None
Results First Post Date:
2025-05-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-12
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL